The Global Biomedical Foundation (GBF) specializes in the collection, storage and distribution of rare and highly characterized biological samples such as disease state plasma to meet clinical research management requirements. GBF takes pride in contributing to research by providing access to high quality and well-annotated biospecimen materials with full regulatory compliance. GBF works with a network of laboratories, clinics and medical doctors, located in Latin America which identify and collect clinically significant blood products. GBF specializes primarily in infectious diseases. They serve the market for biological materials for pharmacogenomics, from non-infectious diseases, genetic disorders to immune-allergies.
According to Maykel Hernandez, COO for GBF, "The first objective was to find a system that would drive compliance with CDC standards so that they could facilitate accreditation and the associated audit requirements. The second was to replace all the manual reports with online reports. Our turn-around time was too long and we were doing a lot of typing into spreadsheets for reporting."
GBF started looking for a sample management solution that was intuitive, user friendly and configurable. The aim was to use a best-in-class solution and to establish laboratory-wide consistency. GBF personnel learned about CloudLIMS's SaaS model while attending the largest biobanking congress, ISBER. After taking an online demo, they determined that the product was in line with their laboratory needs and the overall business plan. Most importantly, it was a system that they did not have to set up, deploy or manage themselves, especially when resources were being consumed managing the business needs.
CloudLIMS's CloudLIMS enabled the GBF network to enter information from different geographic locations, in real time, to a central system. This helped them organize the data rapidly and bring up lab efficiencies, ramp up productivity and maintain sample integrity. CloudLIMS's role based security provides secure access. The lab is now able to record the patient/donor information separately and mask the data at the field level.
Since its implementation, CloudLIMS (SaaS model) has operated efficiently and has proven to be a significant benefit to GBF. Data is entered on a timely basis and shared department-wise. CloudLIMS has improved the security of data entry and has greatly assisted in sample identification and tracking. The new system is a significant factor in receiving CDC certification. The key was the inherent traceability and built-in audit trail.